Abstract: Seven-transmembrane (7TM) receptors are one of the most important proteins involved in perception of extracellular stimuli and regulation of variety of intracellular signaling pathways. Divergence of receptor types, their ligands and signaling pathways makes 7TM receptors important factors in pathology of many diseases. This review focused on the main diseases in which involvement of 7TM receptors was established e.g., retinitis pigmentosa, severe obesity, and dwarfism.
7TM receptors and diseases 34 much higher. Sequence of these receptors is highly variable and the only homology between all 7TM receptors is the presence of seven α-helical transmembrane segments joined by intra-and extracellular loops with N-terminal chain located in the extracellular space and C-terminal chain located in cytoplasm. 7TM receptors react in response to a varied range of stimuli e.g., light, ions, peptides, lipids, and odorants. Upon ligand binding 7TM receptors constrain conformational change in α subunit of trimeric G-protein complex. This leads to exchange of GDP molecule for GTP and dissociation of G-protein and activation of subsequent intracellular responses (BOURNE et al. 1991) .
Biological significance of 7TM receptors was consolidated after reports
showing that heterotrimeric G-proteins are common, although not exclusive, mediators of cellular response after activation of these molecules (PIERCE et al. 2001; PIERCE et al. 2002) . Unusual diversity among 7TM receptors allow them to play an important role in wide spectrum of biological processes ranging from neurotransmission and hormonal control to perception of taste, smell, light and pain.
Divergence of stimuli and rich pattern of intracellular signaling pathways governed by 7TM receptors makes this group of proteins undoubtedly prone to be involved in many pathological processes. In most cases mutation will exhibit as gain/loss of function phenotype of 7TM receptor. As a result of inherited mutations aberrant receptor will be present in every cell expressing particular gene while in somatic mutations even in the case of ubiquitous gene the expression of mutated gene will be limited to the cells derived from the progenitor of mutation (SPIEGEL 1997) .
Mutations in nearly every part of the receptor may cause improper protein expression, folding, endoplasmic reticulum retention, or inability to interact with other proteins of the signalosome. Such abnormalities will exhibit loss of function phenotype and its presence will lead to ligand resistance. Mutations which lead to loss of function mutations are usually recessive and unveil their presence in At present several separate disease entities caused by mutations in 7TM receptors have been described. However, this number is likely to grow fast given to the fact, that over 160 7TM receptors are targeted in mice for homology with human diseases (SCHONEBERG et al. 2004 ).
DISEASES CAUSED BY INACTIVATION MUTATIONS IN 7TM

RECEPTORS
The chances of mutational inactivation of the receptor are high. Amino acid substitution, deletion or insertion may cause loss or prematurely terminated transcription, improper protein folding or its inability to reach cell surface. 
Rhodopsin mutations and retinitis pigmentosa
A growing list of over 150 mutations, most of them missense or small in frame deletions, are primary causes of retinitis pigmentosa. Patients carrying this phenotypically and genetically diverse disease suffer from retinal dystrophy with symptoms ranging from night blindness to progressive loss of visual field (SCHONEBERG et al. 2004; TAO 2006 ).The first ever described mutation that causes this disease in humans was P23H substitution in rhodopsin. Mutated rhodopsin is retained in endoplasmic reticulum due to misfolding and aggregation. Although 
Leptin/Melanocortin circuit; melanocortin receptor and severe obesity
Circulating leptin levels give the brain a reading of energy storage for the purposes of regulating appetite and metabolism. Leptin works by inhibiting the activity of neurons that contain neuropeptide Y (NPY) and agouti-related peptide (AgRP), and by increasing the activity of neurons expressing melanocytestimulating hormone (MSH).
Melanocortins are an important mediator of satiety. Leptin is produced in the adipocytes and mutations in the gene for the melanocortin receptors (MCRs) are linked to obesity in humans (TAO 2005) . MC3R seems to exert its function in fat depository processes, rather than regulation of food intake. Inactivation of MC3R in mice results in elevated amount of fat mass while total body weight remains A. I. CYGANKIEWICZ 37 unchanged (BUTLER et al. 2000; CHEN et al. 2000) . Only recently first mutations of MC3R in obese patients were identified (LEE et al. 2002; RACHED et al. 2004; TAO, SEGALOFF 2004) , confirming the importance of MC3R receptor in maintaining energy balance in the body. Heterozygous MC4 receptor mutations are found in 1-6% of severe cases of human obesity. More than 50 mutations in MC4 receptor gene, many of which were identified as heterozygous missense mutations, linked to obesity have been described in adults with morbid obesity or children with early onset obesity (GOVAERTS et al. 2005) . The exact mechanism of observed dominantnegative effect of mutated MC4R is still far being clear, however recent reports suggest that altered sequence of MC4R may contribute to aberrant formation of multimeric complexes (BIEBERMANN et al. 2003) .
7TM receptors mutations and reproductive physiology
Gonadothropin releasing hormone (GnRH) plays pivotal role in neuroendocrine regulation of reproduction. Hypogonadotropic hypogonadism occurs in patients with lack of GnRH receptor function. Characteristic for this disease is absence or decreased function of male testes or the female ovaries. Follitropin (FSH) receptor inefficiency is responsible for female infertility due to ovarian dysgenesis.
At least 22 mutations in lutropin (LH) receptor responsible for production of testosterone have been reported to cause pseudohermaphroditis in males and hypergonadotropic hypogonadism, and primary amenorrhea in females (TAO 2006).
Growth hormone releasing hormone receptors and dwarfism
Growth hormone releasing hormone (GHRH) is synthesized and secreted by the arcuate nucleus of the hypothalamus. GHRH stimulates synthesis and secretion of growth hormone. Defective signaling in GHRH axis results in somatotroph hypoplasia and growth deficiency. GHRH receptor mutation was first identified in little mouse strain. Mutated murine GHRH receptor is unable to bind its ligand properly. In humans mutant receptors show aberrant signaling (TAO 2006) .
Inactivating mutations of growth hormone releasing hormone receptor lead to isolated growth hormone (GH) deficiency (LIN-SU, WAJNRAJCH 2002) . At the same 7TM receptors and diseases 38 time overexpression of GHRH was found to be an important factor in development of pituitary adenomas in mice (MAYO et al. 1988) . 
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ABERRANT 7TM RECEPTORS EXPRESSION IN NEOPLASMS
Alterations in expression of different 7TM receptors have been reported in numerous human both benign and malignant neoplasms. It has been showed that aberrant expression of gastric inhibitory polypeptide and luteinizing hormone receptors is a sufficient event to trigger hyperplastic growth of adrenogortical cells (MAZZUCO et al. 2007) . Systematic study of data from microarray analysis of primary lung, breast, prostate, gastric and melanoma cancers has revealed that A. I. CYGANKIEWICZ 39 expression of multiple e.g., chemokine, PAR, neuropeptide, adenosine, purine and calcium receptors are significantly upregulated in human neoplasms (LI et al. 2005 ). Tables 1a and 1b . 
Summary of latest findings on changes in 7TM receptors expression changes in various human neoplasms is presented in
COMMERCIAL POTENTIAL OF 7TM RECEPTORS
7TM receptors are one of the most studied targets for present and future 
